An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis

INTRODUCTION: The aim of the study was to compare adalimumab or golimumab with infliximab in patients with moderately-to-severely active ulcerative colitis (UC). MATERIAL AND METHODS: This paper was prepared according to the PRISMA guidelines. The systematic literature search was performed in PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawalec, Paweł, Pilc, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Systematic review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016577/
https://www.ncbi.nlm.nih.gov/pubmed/27695502
http://dx.doi.org/10.5114/aoms.2016.58682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016577/
https://www.ncbi.nlm.nih.gov/pubmed/27695502
http://dx.doi.org/10.5114/aoms.2016.58682

Ejemplares similares